Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience
JAMA Neurol
.
2024 Jan 1;81(1):87.
doi: 10.1001/jamaneurol.2023.4395.
Authors
Andrew B Wolf
1
,
Enrique Alvarez
1
,
John R Corboy
1
Affiliation
1
Rocky Mountain Multiple Sclerosis Center & Department of Neurology, University of Colorado School of Medicine, Aurora.
PMID:
37983039
DOI:
10.1001/jamaneurol.2023.4395
No abstract available
MeSH terms
Humans
Immunosuppressive Agents
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting* / drug therapy
Recurrence
Substances
Immunosuppressive Agents